Literature DB >> 8843103

A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol.

M Naoi1, W Maruyama, P Dostert, K Kohda, T Kaiya.   

Abstract

In the human brain, only (R)enantiomer of 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline ((R)salsolinol) and N-methyl-salsolinol, a dopaminergic neurotoxin, were detected, suggesting their enzymatic biosynthesis. This paper reports the isolation and characterization of a novel enzyme, which enantio-selectively synthesizes (R)salsolinol from dopamine and acetaldehyde. Dopamine, acetaldehyde, formaldehyde and pyruvic acid were the substrates of this synthase, whereas N-methyldopamine, adrenaline, noradrenaline and L-DOPA were not. The possible function of this enzyme under physiological and pathological conditions in the brain is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843103     DOI: 10.1016/0304-3940(96)12807-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains.

Authors:  Yulin Deng; Yongqian Zhang; Yujuan Li; Shengyuan Xiao; Dewei Song; Hong Qing; Qin Li; Ali H Rajput
Journal:  J Neural Transm (Vienna)       Date:  2011-11-08       Impact factor: 3.575

Review 2.  Not Just from Ethanol. Tetrahydroisoquinolinic (TIQ) Derivatives: from Neurotoxicity to Neuroprotection.

Authors:  Alessandra T Peana; Valentina Bassareo; Elio Acquas
Journal:  Neurotox Res       Date:  2019-05-02       Impact factor: 3.911

Review 3.  Parkinson's disease: oxidative stress and therapeutic approaches.

Authors:  Sankar Surendran; Srinivasagam Rajasankar
Journal:  Neurol Sci       Date:  2010-03-10       Impact factor: 3.307

4.  Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells.

Authors:  T Takahashi; W Maruyama; Y Deng; P Dostert; D Nakahara; T Niwa; S Ohta; M Naoi
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  A critical evaluation of influence of ethanol and diet on salsolinol enantiomers in humans and rats.

Authors:  Jeongrim Lee; Vijay A Ramchandani; Kei Hamazaki; Eric A Engleman; William J McBride; Ting-Kai Li; Hee-Yong Kim
Journal:  Alcohol Clin Exp Res       Date:  2009-11-24       Impact factor: 3.455

6.  Computational Modeling of Inclusion Complexes of β-Cyclodextrin with enantiomers of Salsolinol, N-Methyl-Salsolinol, and 1-Benzyl-Tetrahydroisoquinoline.

Authors:  Ming-Ju Huang; Zhe Quan; Yi-Ming Liu
Journal:  Int J Quantum Chem       Date:  2009       Impact factor: 2.444

Review 7.  Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.

Authors:  Thomas S Guillot; Gary W Miller
Journal:  Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.590

8.  Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.

Authors:  Agnieszka Wąsik; Irena Romańska; Jerzy Michaluk; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2015-02-25       Impact factor: 3.911

9.  Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system.

Authors:  Edyta Możdżeń; Małgorzata Kajta; Agnieszka Wąsik; Tomasz Lenda; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2014-12-24       Impact factor: 3.911

10.  Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD?

Authors:  Veit Roessner; Susanne Walitza; Franz Riederer; Regina Hünnerkopf; Aribert Rothenberger; Manfred Gerlach; Andreas Moser
Journal:  Behav Brain Funct       Date:  2007-12-10       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.